Literature DB >> 21878147

Seroepidemiology of Toxoplasma gondii infection in women from the North of Portugal in their childbearing years.

A P Lopes1, J P Dubey, O Moutinho, M J Gargaté, A Vilares, M Rodrigues, L Cardoso.   

Abstract

Seroprevalence of Toxoplasma gondii infection and associated risk factors were investigated in 401 women of childbearing age from the North of Portugal. Of the 98 (24·4%) seropositive women, 92 (93·9%) only had immunoglobulin (Ig)G, two (2·0%) only had IgM, and four (4·1%) others had both IgG and IgM. Risk factors for T. gondii infection in women were: engaging in soil-related activities without gloves [odds ratio (OR) 8·4], consumption of unwashed raw vegetables or fruit (OR 7·6), and consumption of smoked or cured (non-cooked) processed pork products (OR 2·5). Most women of childbearing age from the North Portugal are susceptible to primary infection with T. gondii and, therefore, the risk of congenital toxoplasmosis remains high.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21878147     DOI: 10.1017/S0950268811001658

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  22 in total

1.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

2.  Toxoplasmosis awareness, seroprevalence and risk behavior among pregnant women in the Gampaha district, Sri Lanka.

Authors:  Nilmini Chandrasena; Rasika Herath; Nawamalika Rupasinghe; Buddhini Samarasinghe; Hasaranga Samaranayake; Anuradhani Kastuririratne; Nilanthi Renuka de Silva
Journal:  Pathog Glob Health       Date:  2016-04-19       Impact factor: 2.894

3.  ACUTE TOXOPLASMOSIS IN A BREASTFED INFANT WITH POSSIBLE TRANSMISSION BY WATER.

Authors:  Jaqueline Dario Capobiango; Regina Mitsuka-Breganó; Thais Cabral Monica; Fernanda Pinto Ferreira; Edna Maria Vissoci Reiche
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

4.  Seroepidemiology and risk factors of Toxoplasma gondii infection in undergraduate university female students in Jordan.

Authors:  M M Obaidat; N A Al-Sheyab; A E Bani Salman; S Q Lafi
Journal:  Epidemiol Infect       Date:  2014-12-29       Impact factor: 4.434

5.  Seroprevalence and associated risk factors of Toxoplasma gondii infection in psychiatric patients: a case-control study in eastern China.

Authors:  W Cong; W Dong; L Bai; X-Y Wang; X-T Ni; A-D Qian; X-Q Zhu
Journal:  Epidemiol Infect       Date:  2015-02-17       Impact factor: 4.434

6.  Portugal and Angola: similarities and differences in Toxoplasma gondii seroprevalence and risk factors in pregnant women.

Authors:  M L Lobo; G Patrocinio; T Sevivas; B DE Sousa; O Matos
Journal:  Epidemiol Infect       Date:  2016-09-09       Impact factor: 4.434

7.  Prevalence of antibodies to Leishmania infantum and Toxoplasma gondii in horses from the north of Portugal.

Authors:  Ana Patrícia Lopes; Susana Sousa; J P Dubey; Ana J Ribeiro; Ricardo Silvestre; Mário Cotovio; Henk D F H Schallig; Luís Cardoso; Anabela Cordeiro-da-Silva
Journal:  Parasit Vectors       Date:  2013-06-17       Impact factor: 3.876

8.  Seroprevalence and associated risk factors of Toxoplasma gondii infection in the Korean, Manchu, Mongol and Han ethnic groups in eastern and northeastern China.

Authors:  X-X Zhang; Q Zhao; C-W Shi; W-T Yang; Y-L Jiang; Z-T Wei; C-F Wang; G-L Yang
Journal:  Epidemiol Infect       Date:  2016-02-02       Impact factor: 4.434

9.  Age-associated prevalence of Toxoplasma gondii in 8281 pregnant women in Poland between 2004 and 2012.

Authors:  D Nowakowska; W Wujcicka; W Sobala; E Spiewak; Z Gaj; J Wilczyński
Journal:  Epidemiol Infect       Date:  2013-05-31       Impact factor: 4.434

10.  Seroepidemiology of Toxoplasma gondii infection in the Israeli population.

Authors:  M Perry Markovich; T Shohat; I Riklis; R Avni; D Yujelevski-Rozenblit; R Bassal; D Cohen; E Rorman
Journal:  Epidemiol Infect       Date:  2013-04-15       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.